NAFPENZAL DC
  • Benzilpenicilīna prokaīna sāls
  • Nafcilīna nātrija sāls
  • Valid
Authorised in these countries:
  • Cyprus
Export to PDF

Product identification

Medicine name:
NAFPENZAL DC
Active substance and strength:
  • Benzilpenicilīna prokaīna sāls
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Nafcilīna nātrija sāls
    100.00
    milligram(s)
    /
    1.00
    Syringe
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51GA90
  • QJ51RC
  • QJ51RC22
Authorisation number:
  • CY00072V
Product identification number:
  • 85f5fd43-1a67-4dd0-8b14-9e8b44c65e64
Permanent identification number:
  • 600000094126

Product details

Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Goat
      • Meat and offal
        35
        day
      • Milk
        9
        day
    • Sheep
      • Meat and offal
        35
        day
      • Milk
        90
        day
    • Cattle (dairy cow)
      • Meat and offal
        48
        hour
      • Meat and offal
        16
        day

Availability

Package description:
Manufacturing sites for batch release:
  • Intervet International B.V.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
This information is not available for this product.
Date of authorisation status change:
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Authorisation country:
  • Cyprus
Responsible authority:
  • Ministry Of Agriculture Rural Development And Environment
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."